As part of the EU-funded EBRAINS 2.0 project, we are excited to announce a special issue in the European Journal of Neurology, inviting researchers to contribute original studies that explore the intersection of neuroscience, digital innovation, and its clinical applications.

WFN to elect new President, Vice President and Elected Trustee in September. 'Brain Health for all Ages' chosen as theme for WBD 2025.

Our summary of neurological news items the European Medicines Agency (EMA) monthly Human Medicines Newsletter.

This month, the eanCampus is highlighting the topic of Child Neurology, with several pieces of content freely accessible for non-members to enjoy.

Neuroscientists, Professors Michelle Monje and Frank Winkler, have been awarded The Brain Prize 2025, the world’s largest award for outstanding contributions to neuroscience.

Dr Magdalini Krommyda, an EAN Ambassador of Neurology and Brain Health, shares Greece’s innovative initiatives aimed at enhancing brain health and preventing cognitive decline.

We are pleased to announce two Joint Sessions co-hosted by the EAN at the 33rd European Congress of Psychiatry (Madrid, 5-8 April)

Reports from three EAN Clinical Fellowship participants on their experiences in Utrecht (NL), Dianalund (DK), and London (UK).

In the lead-up to Brain Awareness Week, the European Brain Council is happy to announce that it will hold its annual event, focusing on the establishment of brain health plans.

EAN Treasurer, Jana Midelfart-Hoff reviews her "fantastic experience" in office over the last six months, representing the EAN and the Brain Health Mission on various levels

Welcome to the February 2025 edition of the President’s Corner, our article series in which the EAN President, Elena Moro, answers your questions!

Each month the eanNews editorial team reviews the scientific press for recently published papers of outstanding interest to neurologists. Here we present our selection for February 2025.

For February we have selected two co-papers of the month, each of which examines the safety and efficacy of a specific drug in the treatment of patients with generalised myasthenia gravis.

To recognise and encourage excellence, the EBN has introduced a special award for the top-performing candidates.

We are delighted to invite you to Porto, Portugal, to take part in the EAN Regional Teaching Course on 13-15 March 2025.